1Gokal R, Hutchison A. Dialysis therapies for end-stage renal disease [ J ]. Semin Dial, 2002,15 (4) : 220 -226.
2Locatelli F, Pozzoni P, Del VL. Renal replacement therapy in patients with diabetes and end-stage renal disease[J]. J Am Soc Nephrol,2004,15Suppl1:25-29.
3Schulman G. The role of hemodialysis and peritoneal dialysis for the early initiation of dialysis [ J ]. Blood Purif, 2001,19(2) :175-178.
4Coles GA. Clinical research in peritoneal dialysis [ J ]. Contrib Nephrol,2001, ( 131 ) : 125-131.
5Gokal R. Peritoneal dialysis in the 21st century:an analysis of current problems and future developments [ J ]. J Am Soc Nephrol,2002,13Suppl1 : 104-116.
6Grzegorzewska AE. What is new in peritoneal dialysis in the years 2003-2004 [ J ]. Rocz Akad Med Bialymst, 2004,49 : 170-173.
7Herhahdez D, Diaz F, Rufino M, et al. Subvlavian vascular access stemosis in dialysis patients : natural history and risk factors [ J ]. J Am Soc Nephrol, 1998,9 ( 8 ) : 1507- 1510.
8[8]Sergio De Marrchi,Ednondo Falleti, Risk factors for vascular Disease and Arterivenous Fistula dysfuction in hemodialysis patients. JASN.1996,7:1169-1177
7Passadakis P,Thodis E.Long-tem survival with peritoneal dialysis in ESRD due to diabetes[J].Clin Nephrol,2001,569(3):257.
8Peter GB. Advantages and disadvanges of automated peritoneaL diaLysis compared to continuous ambulatory peritoneaLdiaLysis[J]. Petit DiaLInt, 1999, 19 (suppL 2) :S121.
9Thomas C M,Zhang J,Lim T H,et al.Concentration of heparin-locking solution and risk of central venous hernodialysis catheter malfunction[J].ASAIO J,2007,53(4):485.
10Oran N T,FEser I.Impact of heparin locking frequency on preventing temporary dialysis catheter dysfunction in haemodialysis patients[J].J Ren Care,2008,34(4):199.
